Traveler"s diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
The global Traveler's Diarrhea Therapeutics market size was valued at US$ 870 million in 2023 and is forecast to a readjusted size of USD 1384 million by 2030 with a CAGR of 6.9% during review period.
North America is the largest Traveler"s Diarrhea Therapeutics market with about 45% market share. Europe is follower, accounting for about 42% market share.The key manufacturers are Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron etc. Top 3 companies occupied about 35% market share.
This report is a detailed and comprehensive analysis for global Traveler's Diarrhea Therapeutics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Traveler's Diarrhea Therapeutics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Traveler's Diarrhea Therapeutics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Traveler's Diarrhea Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global Traveler's Diarrhea Therapeutics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Traveler's Diarrhea Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Traveler's Diarrhea Therapeutics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Traveler's Diarrhea Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Others
麻豆原创 segment by Application
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
Major players covered
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Traveler's Diarrhea Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Traveler's Diarrhea Therapeutics, with price, sales quantity, revenue, and global market share of Traveler's Diarrhea Therapeutics from 2019 to 2024.
Chapter 3, the Traveler's Diarrhea Therapeutics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Traveler's Diarrhea Therapeutics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Traveler's Diarrhea Therapeutics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Traveler's Diarrhea Therapeutics.
Chapter 14 and 15, to describe Traveler's Diarrhea Therapeutics sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Traveler's Diarrhea Therapeutics Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Immunization
1.3.3 Non-antibiotic Agents
1.3.4 Antibiotics
1.3.5 Anti-Motility Agents
1.3.6 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Traveler's Diarrhea Therapeutics Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Adult Traveler's Diarrhea
1.4.3 Children Traveler's Diarrhea
1.5 Global Traveler's Diarrhea Therapeutics 麻豆原创 Size & Forecast
1.5.1 Global Traveler's Diarrhea Therapeutics Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Traveler's Diarrhea Therapeutics Sales Quantity (2019-2030)
1.5.3 Global Traveler's Diarrhea Therapeutics Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Salix Pharmaceuticals
2.1.1 Salix Pharmaceuticals Details
2.1.2 Salix Pharmaceuticals Major Business
2.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product and Services
2.1.4 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Salix Pharmaceuticals Recent Developments/Updates
2.2 P&G
2.2.1 P&G Details
2.2.2 P&G Major Business
2.2.3 P&G Traveler's Diarrhea Therapeutics Product and Services
2.2.4 P&G Traveler's Diarrhea Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 P&G Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Product and Services
2.3.4 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 Otsuka Pharma
2.4.1 Otsuka Pharma Details
2.4.2 Otsuka Pharma Major Business
2.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Product and Services
2.4.4 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Otsuka Pharma Recent Developments/Updates
2.5 Valneva
2.5.1 Valneva Details
2.5.2 Valneva Major Business
2.5.3 Valneva Traveler's Diarrhea Therapeutics Product and Services
2.5.4 Valneva Traveler's Diarrhea Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Valneva Recent Developments/Updates
2.6 Shanghai United Cell
2.6.1 Shanghai United Cell Details
2.6.2 Shanghai United Cell Major Business
2.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Product and Services
2.6.4 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Shanghai United Cell Recent Developments/Updates
2.7 PaxVax
2.7.1 PaxVax Details
2.7.2 PaxVax Major Business
2.7.3 PaxVax Traveler's Diarrhea Therapeutics Product and Services
2.7.4 PaxVax Traveler's Diarrhea Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 PaxVax Recent Developments/Updates
2.8 Livzon
2.8.1 Livzon Details
2.8.2 Livzon Major Business
2.8.3 Livzon Traveler's Diarrhea Therapeutics Product and Services
2.8.4 Livzon Traveler's Diarrhea Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Livzon Recent Developments/Updates
2.9 Immuron
2.9.1 Immuron Details
2.9.2 Immuron Major Business
2.9.3 Immuron Traveler's Diarrhea Therapeutics Product and Services
2.9.4 Immuron Traveler's Diarrhea Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Immuron Recent Developments/Updates
3 Competitive Environment: Traveler's Diarrhea Therapeutics by Manufacturer
3.1 Global Traveler's Diarrhea Therapeutics Sales Quantity by Manufacturer (2019-2024)
3.2 Global Traveler's Diarrhea Therapeutics Revenue by Manufacturer (2019-2024)
3.3 Global Traveler's Diarrhea Therapeutics Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Traveler's Diarrhea Therapeutics by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Traveler's Diarrhea Therapeutics Manufacturer 麻豆原创 Share in 2023
3.4.3 Top 6 Traveler's Diarrhea Therapeutics Manufacturer 麻豆原创 Share in 2023
3.5 Traveler's Diarrhea Therapeutics 麻豆原创: Overall Company Footprint Analysis
3.5.1 Traveler's Diarrhea Therapeutics 麻豆原创: Region Footprint
3.5.2 Traveler's Diarrhea Therapeutics 麻豆原创: Company Product Type Footprint
3.5.3 Traveler's Diarrhea Therapeutics 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Traveler's Diarrhea Therapeutics 麻豆原创 Size by Region
4.1.1 Global Traveler's Diarrhea Therapeutics Sales Quantity by Region (2019-2030)
4.1.2 Global Traveler's Diarrhea Therapeutics Consumption Value by Region (2019-2030)
4.1.3 Global Traveler's Diarrhea Therapeutics Average Price by Region (2019-2030)
4.2 North America Traveler's Diarrhea Therapeutics Consumption Value (2019-2030)
4.3 Europe Traveler's Diarrhea Therapeutics Consumption Value (2019-2030)
4.4 Asia-Pacific Traveler's Diarrhea Therapeutics Consumption Value (2019-2030)
4.5 South America Traveler's Diarrhea Therapeutics Consumption Value (2019-2030)
4.6 Middle East & Africa Traveler's Diarrhea Therapeutics Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Traveler's Diarrhea Therapeutics Sales Quantity by Type (2019-2030)
5.2 Global Traveler's Diarrhea Therapeutics Consumption Value by Type (2019-2030)
5.3 Global Traveler's Diarrhea Therapeutics Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Traveler's Diarrhea Therapeutics Sales Quantity by Application (2019-2030)
6.2 Global Traveler's Diarrhea Therapeutics Consumption Value by Application (2019-2030)
6.3 Global Traveler's Diarrhea Therapeutics Average Price by Application (2019-2030)
7 North America
7.1 North America Traveler's Diarrhea Therapeutics Sales Quantity by Type (2019-2030)
7.2 North America Traveler's Diarrhea Therapeutics Sales Quantity by Application (2019-2030)
7.3 North America Traveler's Diarrhea Therapeutics 麻豆原创 Size by Country
7.3.1 North America Traveler's Diarrhea Therapeutics Sales Quantity by Country (2019-2030)
7.3.2 North America Traveler's Diarrhea Therapeutics Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Traveler's Diarrhea Therapeutics Sales Quantity by Type (2019-2030)
8.2 Europe Traveler's Diarrhea Therapeutics Sales Quantity by Application (2019-2030)
8.3 Europe Traveler's Diarrhea Therapeutics 麻豆原创 Size by Country
8.3.1 Europe Traveler's Diarrhea Therapeutics Sales Quantity by Country (2019-2030)
8.3.2 Europe Traveler's Diarrhea Therapeutics Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Traveler's Diarrhea Therapeutics Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Traveler's Diarrhea Therapeutics Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Traveler's Diarrhea Therapeutics 麻豆原创 Size by Region
9.3.1 Asia-Pacific Traveler's Diarrhea Therapeutics Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Traveler's Diarrhea Therapeutics Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 South Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Traveler's Diarrhea Therapeutics Sales Quantity by Type (2019-2030)
10.2 South America Traveler's Diarrhea Therapeutics Sales Quantity by Application (2019-2030)
10.3 South America Traveler's Diarrhea Therapeutics 麻豆原创 Size by Country
10.3.1 South America Traveler's Diarrhea Therapeutics Sales Quantity by Country (2019-2030)
10.3.2 South America Traveler's Diarrhea Therapeutics Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Traveler's Diarrhea Therapeutics Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Traveler's Diarrhea Therapeutics Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Traveler's Diarrhea Therapeutics 麻豆原创 Size by Country
11.3.1 Middle East & Africa Traveler's Diarrhea Therapeutics Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Traveler's Diarrhea Therapeutics Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Traveler's Diarrhea Therapeutics 麻豆原创 Drivers
12.2 Traveler's Diarrhea Therapeutics 麻豆原创 Restraints
12.3 Traveler's Diarrhea Therapeutics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Traveler's Diarrhea Therapeutics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Traveler's Diarrhea Therapeutics
13.3 Traveler's Diarrhea Therapeutics Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Traveler's Diarrhea Therapeutics Typical Distributors
14.3 Traveler's Diarrhea Therapeutics Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
听
听
*If Applicable.
